C-reactive protein adversely alters the protein-protein interaction of the endothelial isoform of nitric oxide synthase

Clinical Chemistry

Volumn 56, Issue 8, 2010, Pages 1345-1348

  Valleggi, Simona ^a   Devaraj, Sridevi ^a   Dasu, Mohan R ^a   Jialal, Ishwarlal ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CAVEOLIN 1; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HEAT SHOCK PROTEIN 90; PORIN;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING;

C-REACTIVE PROTEIN; CAVEOLIN 1; CELLS, CULTURED; ENDOTHELIAL CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; ISOENZYMES; NITRIC OXIDE SYNTHASE TYPE III; PORINS; PROTEIN BINDING; TIME FACTORS;

EID: 77955261291     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2009.142364     Document Type: Article

References (19)

1. Pepys MB. C-reactive protein fifty years on. Lancet 1981;1:653-7.
2. Ridker PM. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin Chem 2009;55:209-15.
3. Devaraj S, Singh U, Jialal I. The evolving role of C-reactive protein in atherothrombosis. Clin Chem 2009;55:229-38.
4. Verma S, Devaraj S, Jialal I. Is C-reactive protein an innocent bystander or proatherogenic culprit? C-reactive protein promotes atherothrombosis. Circulation 2006;113:2135-50.
5. Sessa WC. Molecular control of blood flow and angiogenesis: role of nitric oxide. J Thromb Haemost 2009;7(Suppl 1):35-7.
6. Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol 2003;284:R1-12. (Pubitemid 36008649)
7. Govers R, Rabelink TJ. Cellular regulation of endothelial nitric oxide synthase. Am J Physiol Renal Physiol 2001;280:193-206. (Pubitemid 32473273)
8. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation 2002; 106:1439-41.
9. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106:913-9. (Pubitemid 34925323)
10. Singh U, Devaraj S, Vasquez-Vivar J, Jialal I. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J Mol Cell Cardiol 2007;43:780-91. (Pubitemid 350166380)
11. Jialal I, Verma S, Devaraj S. Inhibition of endothelial nitric oxide synthase by C-reactive protein: clinical relevance. Clin Chem 2009;55:206-8.
12. García-Cardeña G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998;392:821-4. (Pubitemid 28225323)
13. 2+-calmodulin and caveolin. J Biol Chem 1997; 272:15583-6.
14. Ju H, Venema VJ, Marrero MB, Venema RC. Inhibitory interactions of the bradykinin B2 receptor with endothelial nitric-oxide synthase. J Biol Chem 1998;273:24025-9. (Pubitemid 28435743)
15. Sun J, Liao JK. Functional interaction of endothelial nitric oxide synthase with a voltage-dependent anion channel. Proc Natl Acad Sci U S A 2002;99:13108-13.
16. Singh U, Devaraj S, Jialal I. C-reactive protein decreases tissue plasminogen activator activity in human aortic endothelial cells: evidence that C-reactive protein is a procoagulant. Arterioscler Thromb Vasc Biol 2005;25:2216-21. (Pubitemid 41416324)
17. Dasu MR, Devaraj S, Du Clos TW, Jialal I. The biological effects of CRP are not attributable to endotoxin contamination: evidence from TLR4 knockdown human aortic endothelial cells. J Lipid Res 2007;48:509-12. (Pubitemid 46397454)
18. Smart EJ, Graf GA, McNiven MA, Sessa WC, Engelman JA, Scherer PE, et al. Caveolins, liquid-ordered domains, and signal transduction. Mol Cell Biol 1999;19:7289-304.
19. Pratt WB. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu Rev Pharmacol Toxicol 1997;37:297-326.